Literature DB >> 23709194

Noninvasive ventilation for acute respiratory failure.

Dean R Hess1.   

Abstract

Noninvasive ventilation (NIV) for acute respiratory failure has gained much academic and clinical interest. Despite this, NIV is underutilized. The evidence strongly supports its use in patients presenting with an exacerbation of COPD and in patients with acute cardiogenic pulmonary edema. As reviewed in this paper, there is now evidence supporting or not supporting the use of NIV in various other presentations of acute respiratory failure. It is important not only to know when to initiate NIV, but also when this therapy is failing. Whether NIV in the setting of acute respiratory failure can be managed appropriately outside the ICU setting is controversial. Although a variety of interfaces are available, the oronasal mask is the best initial interface in terms of leak prevention and patient comfort. Some critical care ventilators have NIV modes that compensate well for leaks, but as a group the ventilators that are designed specifically for NIV have better leak compensation. NIV should be part of the armamentarium of all clinicians caring from patients with acute respiratory failure.

Entities:  

Keywords:  COPD; acute cardiogenic pulmonary edema; acute respiratory failure; noninvasive ventilation

Mesh:

Year:  2013        PMID: 23709194     DOI: 10.4187/respcare.02319

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  41 in total

1.  Noninvasive and invasive positive pressure ventilation for acute respiratory failure in critically ill patients: a comparative cohort study.

Authors:  Annelijn M Meeder; Dave H T Tjan; Arthur R H van Zanten
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

2.  Phantom testing of the sensitivity and precision of a sub-epidermal moisture scanner.

Authors:  Lea Peko Cohen; Amit Gefen
Journal:  Int Wound J       Date:  2019-04-16       Impact factor: 3.315

3.  Non-invasive ventilation in acute respiratory failure: the key "W" questions.

Authors:  Eliana Margutti; Ilaria Greco; Anna Maria Brambilla; Tommaso Maraffi; Roberto Cosentini
Journal:  Intern Emerg Med       Date:  2017-08-14       Impact factor: 3.397

4.  Natural history and risk stratification of patients undergoing non-invasive ventilation in a non-ICU setting for severe COPD exacerbations.

Authors:  Pier Paolo Sainaghi; Azzurra Re; Mattia Bellan; Paolo Navalesi; Mario Pirisi
Journal:  Intern Emerg Med       Date:  2016-08-02       Impact factor: 3.397

5.  Non-invasive ventilation for COPD exacerbations in a non-ICU setting.

Authors:  João Cravo; Antonio Esquinas
Journal:  Intern Emerg Med       Date:  2016-07-11       Impact factor: 3.397

6.  ATS Core Curriculum 2016: Part II. Adult Critical Care Medicine.

Authors:  Jakob I McSparron; Margaret M Hayes; Jason T Poston; Carey C Thomson; Henry E Fessler; Renee D Stapleton; W Graham Carlos; Laura Hinkle; Kathleen Liu; Stephanie Shieh; Alyan Ali; Angela Rogers; Nirav G Shah; Donald Slack; Bhakti Patel; Krysta Wolfe; William D Schweickert; Rita N Bakhru; Stephanie Shin; Rebecca E Sell; Andrew M Luks
Journal:  Ann Am Thorac Soc       Date:  2016-05

Review 7.  Critical asthma syndrome in the ICU.

Authors:  Michael Schivo; Chinh Phan; Samuel Louie; Richart W Harper
Journal:  Clin Rev Allergy Immunol       Date:  2015-02       Impact factor: 8.667

8.  Thermography as a tool for monitoring the interface between the noninvasive ventilation mask and the skin.

Authors:  Bruno do Valle Pinheiro
Journal:  J Bras Pneumol       Date:  2017 Mar-Apr       Impact factor: 2.624

9.  The evidence is in: noninvasive ventilation saves lives.

Authors:  Dean R Hess
Journal:  Crit Care Med       Date:  2015-04       Impact factor: 7.598

10.  Where is Noninvasive Ventilation Actually Delivered for Acute Respiratory Failure?

Authors:  Aylin Ozsancak Ugurlu; Samy S Sidhom; Ali Khodabandeh; Michael Ieong; Chester Mohr; Denis Y Lin; Irwin Buchwald; Imad Bahhady; John Wengryn; Vinay Maheshwari; Nicholas S Hill
Journal:  Lung       Date:  2015-07-26       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.